C
Generic Name: mycophenolic acid
Pill imprint C has been identified as Myfortic 180 mg.
Myfortic is used in the treatment of rejection prophylaxis; dermatomyositis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy.
Myfortic 180 mg is not subject to the Controlled Substances Act.
See also related documents.
Myfortic Images
- Generic Name:
- mycophenolic acid
- Imprint:
-
C
- Strength:
- 180 mg
- Color:
- Green
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
crospovidone
hypromelloses
FD&C Blue No. 2
ferric oxide yellow
lactose anhydrous
magnesium stearate
povidone k30
corn starch
titanium dioxide
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0385
Advertisement
More Myfortic resources
- Myfortic
- Myfortic Delayed-Release Tablets (Wolters Kluwer)
- Myfortic (Cerner Multum)
- Myfortic (Micromedex) - Includes Dosage Information
- Myfortic (FDA)
Search Again
